Found: 2
Select item for more details and to access through your institution.
Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
- Published in:
- Surgical Technology International, 2021, v. 38, p. 1
- By:
- Publication type:
- Article
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis.
- Published in:
- Journal of Pain Research, 2018, v. 11, p. 151, doi. 10.2147/JPR.S135257
- By:
- Publication type:
- Article